Furthermore, survival analyses based on gene expression (TCGA & GTEx profile) and mutational status (TCGA COAD & Pan‐cancer datasets) for colon adenocarcinoma identified CDKN2A, INHBA increased expression, and CDKN2A and TCF7L2 mutations as predictors of bad prognosis in metastatic patients (Table 1). This evidence concerns the gene CDKN2A and cancer.